SHP2 Inhibitor BBP-398 in Combination With Sotorasib in Patients With Advanced Solid Tumors and a KRAS-G12C Mutation

Peninsula & South Eastern Haematology and Oncology Group, Frankston

Cancer Research SA, Adelaide

Southern Oncology Clinical Research Unit, Adelaide

St John of God Subiaco Hospital, Subiaco

One Clinical Research, Perth

Centre Georges François Leclerc, Dijon

Spedali Civili - Brescia, Brescia

Clinica Universidad de Navarra, Madrid

Quiron Salud Madrid, Madrid

Virgen De La Victoria, Málaga

Institute Bergonie, Bordeaux

CHU de Rennes - Hôpital Pontchaillou, Rennes

Careggi University Hospital, Florence

St. Luke's Hospital S.A., Thessaloniki

Hopital Bichat-Claude Bernard, Paris

"Istituto Nazionale Tumori (INT) Fondazione G. Pascale", Napoli

"U.O.C Oncoematologia AOU Luigi Vanvitelli", Napoli

Orange Health Service, Orange

Rigshospitalet, Copenhagen

CHU Grenobles Aples, Grenoble

Het Nederlands Kanker Instituut - Antoni van Leewenhoek Ziekenhuis, Amsterdam

Erasmus Medical Center, Rotterdam

Quiron Salud Barcelona, Barcelona

Vall d'Heborn University Hospital - VHIO, Barcelona

Hospital Universitario Virgen De La Macarena, Seville